About
The Fusion Bx™ system enables urologists to co-register MRI prostate images with live ultrasound to accurately target suspicious cancer regions during transrectal ultrasound (TRUS) biopsy procedures. The procedure is augmented by validated non-rigid registration modules for accuracy. The Fusion Bx™ system records the location of the biopsy cores, thereby providing a greatly enhanced methodology for the active surveillance of prostate cancer, and facilitating targeted therapy. The Fusion Tx™ system enables urologists to accurately target and treat cancer lesions within the prostate utilizing any needle-based therapy method. The system seamlessly integrates pathology data and co-registers MR imaging with live ultrasound guidance. The system is streamlined to expedite workflow and greatly improve clinical outcome.